Evidence map›Paper›PMID 34297758›Full record

ArticlePloS one2021

Exercise tolerance and quality of life in hemodynamically partially improved patients with chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty.

Kotaro Miura, Yoshinori Katsumata, Takashi Kawakami, Hidehiko Ikura, Toshinobu Ryuzaki, Yasuyuki Shiraishi, Shogo Fukui, Michiyuki Kawakami, Takashi Kohno, Kazuki Sato and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Kotaro MiuraDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.ORCID 0000-0002-0351-6008
Yoshinori KatsumataDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Takashi KawakamiDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Hidehiko IkuraDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Toshinobu RyuzakiDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Yasuyuki ShiraishiDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Shogo FukuiDepartment of Rehabilitation Medicine, Keio University Hospital, Tokyo, Japan.
Michiyuki KawakamiDepartment of Rehabilitation Medicine, Keio University Hospital, Tokyo, Japan.
Takashi KohnoDepartment of Cardiovascular Medicine, Kyorin University School of Medicine, Mitaka, Tokyo, Japan.
Kazuki SatoInstitute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan.
Keiichi FukudaDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Keio University · JPKeio University Hospital · JPKyorin University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The efficacy of extensive balloon pulmonary angioplasty (BPA) beyond hemodynamic improvement in chronic thromboembolic pulmonary hypertension (CTEPH) patients has been verified. However, the relationship between extensive BPA in CTEPH patients after partial hemodynamic improvement and exercise tolerance or quality of life (QOL) remains unclear. We prospectively enrolled 22 CTEPH patients (66±10 years, females: 59%) when their mean pulmonary artery pressure initially decreased to <30 mmHg during BPA sessions. Hemodynamic and echocardiographic data, cardiopulmonary exercise testing, and QOL scores using the 36-item short form questionnaire (SF-36) were evaluated at enrollment (entry), just after the final BPA session (finish), and at the 6-month follow-up (follow-up). We analyzed whether extensive BPA improves exercise capacity and QOL scores over time. Moreover, the clinical characteristics leading to improvement were elucidated. The peak oxygen uptake (VO2) showed significant improvement at entry, finish, and follow-up (17.3±5.5, 18.4±5.9, and 18.9±5.3 mL/kg/min, respectively; P<0.001). Regarding the QOL, the physical component summary (PCS) scores significantly improved (32±11, 38±13, and 43±13, respectively; P<0.001), but the mental component summary scores remained unchanged. Linear regression analysis revealed that age and a low peak VO2 at entry were predictors of improvement in peak VO2, while low PCS scores and low TAPSE at entry were predictors of improvement in PCS scores. In conclusion, extensive BPA led to improved exercise tolerance and physical QOL scores, even in CTEPH patients with partially improved hemodynamics.

Indexed as

Exercise ToleranceQuality of LifeAgedAngioplasty, BalloonFemaleHemodynamicsHumansHypertension, PulmonaryMaleMiddle AgedOxygen ConsumptionPostoperative ComplicationsPulmonary Embolism

Identifiers

PMID34297758
PMCPMC8301648
OpenAlexW3186684355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.